Skip to main content

Becoming the Industry Leader

Becoming the Industry LeaderAmoena was the first company to introduce revolutionary breast form innovations for breast cancer survivors. Unlike others in the industry, Cornelius was never satisfied with the status quo of breast forms. He continued to research ways to further innovate product design and comfort to create a form that felt more natural. In 1984, Amoena introduced a 2-layer breast form with a firm silicone ‘ring’ on the rear side to stabilise the form in the bra and a new shape that replicated the anatomy of a woman’s breast.

Technological advancement and diversification

Amoena has registered over 25 patent families and has a history rich in growth, technological advancements and diversification.

Here’s a glimpse at some of our proudest moments:

1984 Introduction of 2-layer breast forms
1988 Introduced patented Flowable Gel Back Layer breast forms
1989 Founded first Amoena subsidiaries in Europe
1992 First generation attachable breast forms after a patented manufacturing method
Introduced a line of lingerie for breast cancer survivors post-surgery 
1996 Launched pocketed swimwear
  Introduced lightweight silicone breast forms after a patented manufacturing method
  Introduced second generation attachable breast forms after a patented manufacturing method
2000 Introduced third generation attachable breast forms after a patented manufacturing method
2001 Patented Moldable Back Layer breast forms
2004 Introduced Tawny Lightweight breast forms
2005 Introduced patented Climate breast forms
2008 Patented Comfort+ Technology breast forms
2010 Introduced Amoena Energy breast forms with 3D pearl surface
2010 Launched Amoena's first bra product line designed for the general female consumer, Amoena Mia

Investment in growth

Whereas Cornelius initially had little or no interest from our industry, Amoena’s monumental growth and our position as industry leader eventually captured the attention of other companies. In 1994, Amoena Germany merged with the Breast Care Division of Coloplast A/S DK and eventually all Coloplast Breast Care subsidiaries became Amoena subsidiaries. Then, in 2007, Granville Baird Capital Partners invested in the Amoena Group because of our position as the global market leader.

Amoena serves worldwide post-mastectomy markets including North and Central America, Europe, the Far East, Africa and the Pacific Rim. We market products through hospitals and clinics, and through thousands of specialist boutiques and high-end retailers.

Cornelius's influence continues

Cornelius Rechenberg had a vision and a steadfast determination to revolutionize the manufacturing process of breast forms. Although he passed away in 2001, his influence continues to guide our company’s mission and values. We remain committed to Cornelius’s vision and the women we proudly serve.

Further reading
You may be interested in...